BIO
Bio-Rad Laboratories, Inc.Healthcare · $10.2B market cap
Verdict
Share price
$369.14
close of Oct 3, 2026
Fair value
$154.12
Sticker Price
Payback Price
$61.65
buy price
BIO is Overpriced: at $369.14 it trades 140% above its fair value of $154.12. Its buy price (Payback Price) is $61.65, 83% below today's price. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.
How we valued it
Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.
Business quality
2 of 5 clear the 10% bar. What are the Big Five?
Follow BIO
Get notified when it reaches its buy price of $61.65. Free.
Create a free accountSuperinvestors
3 of the investors we track hold BIO. In Q2 2026, 1 sold out. Who we track
First Eagle Investment Management
First Eagle Investment Management · as of Q2 2026
$765.2M
2,606,219 shares
John Rogers
Ariel Investments · as of Q2 2026
$239.8M
816,751 shares
First Pacific Advisors
First Pacific Advisors · as of Q2 2026
$118.0M
401,861 shares
Moves in Q2 2026
Sold out: Mason Hawkins
Insider activity
Since Jul 25, 2026: no open-market purchases and 57 other filings (stock awards, tax withholding and similar). Why purchases matter
Other filings
SCHWARTZ NORMAN D
Chairman & CEO · 2026-09-06
Tax withholding
$716K
SCHWARTZ NORMAN D
Chairman & CEO · 2026-09-06
Option exercise
3,455 shares
Lakkaraju Roop Kalyan
EVP, Chief Financial Officer · 2026-09-06
Tax withholding
$302K
Lakkaraju Roop Kalyan
EVP, Chief Financial Officer · 2026-09-06
Option exercise
1,536 shares
ENLOE COURTNEY C
EVP, General Counsel & Sec · 2026-09-06
Tax withholding
$118K
Show all 57 other filingsShow fewer
ENLOE COURTNEY C
EVP, General Counsel & Sec · 2026-09-06
Option exercise
768 shares
ENGELHARDT EVA ANETTE
EVP, President, CDG · 2026-09-06
Tax withholding
$187K
ENGELHARDT EVA ANETTE
EVP, President, CDG · 2026-09-06
Option exercise
1,152 shares
EVRAN SEDAT
EVP, Global Supply Chain · 2026-09-06
Tax withholding
$107K
EVRAN SEDAT
EVP, Global Supply Chain · 2026-09-06
Option exercise
864 shares
BARRY JAMES
EVP, President, LSG · 2026-09-06
Tax withholding
$181K
BARRY JAMES
EVP, President, LSG · 2026-09-06
Option exercise
1,056 shares
Allison Schwartz
director · 2026-09-06
Tax withholding
$13K
Allison Schwartz
director · 2026-09-06
Option exercise
92 shares
SCHWARTZ NORMAN D
Chairman & CEO · 2026-09-05
Tax withholding
$1.1M
SCHWARTZ NORMAN D
Chairman & CEO · 2026-09-05
Option exercise
4,109 shares
Lakkaraju Roop Kalyan
EVP, Chief Financial Officer · 2026-09-05
Tax withholding
$216K
Lakkaraju Roop Kalyan
EVP, Chief Financial Officer · 2026-09-05
Option exercise
1,370 shares
Mehta Rajat
EVP, GBL Commercial Operations · 2026-09-05
Tax withholding
$195K
Mehta Rajat
EVP, GBL Commercial Operations · 2026-09-05
Option exercise
1,370 shares
Mehta Rajat
EVP, GBL Commercial Operations · 2026-09-05
Tax withholding
$90K
Mehta Rajat
EVP, GBL Commercial Operations · 2026-09-05
Option exercise
456 shares
ENLOE COURTNEY C
EVP, General Counsel & Sec · 2026-09-05
Tax withholding
$95K
ENLOE COURTNEY C
EVP, General Counsel & Sec · 2026-09-05
Option exercise
685 shares
DiVincenzo Jonathan P.
President & COO · 2026-09-05
Tax withholding
$258K
DiVincenzo Jonathan P.
President & COO · 2026-09-05
Option exercise
1,712 shares
ENGELHARDT EVA ANETTE
EVP, President, CDG · 2026-09-05
Tax withholding
$142K
ENGELHARDT EVA ANETTE
EVP, President, CDG · 2026-09-05
Option exercise
1,027 shares
EVRAN SEDAT
EVP, Global Supply Chain · 2026-09-05
Tax withholding
$127K
EVRAN SEDAT
EVP, Global Supply Chain · 2026-09-05
Option exercise
1,027 shares
BARRY JAMES
EVP, President, LSG · 2026-09-05
Tax withholding
$142K
BARRY JAMES
EVP, President, LSG · 2026-09-05
Option exercise
1,027 shares
Allison Schwartz
director · 2026-09-05
Tax withholding
$32K
Allison Schwartz
director · 2026-09-05
Option exercise
228 shares
SCHWARTZ NORMAN D
Chairman & CEO · 2026-09-04
Award
17,251 shares
Lakkaraju Roop Kalyan
EVP, Chief Financial Officer · 2026-09-04
Award
6,326 shares
Mehta Rajat
EVP, GBL Commercial Operations · 2026-09-04
Award
4,601 shares
ENLOE COURTNEY C
EVP, General Counsel & Sec · 2026-09-04
Award
2,876 shares
DiVincenzo Jonathan P.
President & COO · 2026-09-04
Award
6,326 shares
ENGELHARDT EVA ANETTE
EVP, President, CDG · 2026-09-04
Award
4,313 shares
EVRAN SEDAT
EVP, Global Supply Chain · 2026-09-04
Award
4,026 shares
BARRY JAMES
EVP, President, LSG · 2026-09-04
Award
4,313 shares
Allison Schwartz
director · 2026-09-04
Award
719 shares
SCHWARTZ NORMAN D
Chairman & CEO · 2026-09-01
Option exercise
3,005 shares
SCHWARTZ NORMAN D
Chairman & CEO · 2026-09-01
Option exercise
2,082 shares
SCHWARTZ NORMAN D
Chairman & CEO · 2026-09-01
Tax withholding
$890K
SCHWARTZ NORMAN D
Chairman & CEO · 2026-09-01
Option exercise
5,087 shares
Allison Schwartz
director · 2026-09-01
Option exercise
75 shares
Allison Schwartz
director · 2026-09-01
Option exercise
42 shares
Allison Schwartz
director · 2026-09-01
Tax withholding
$16K
Allison Schwartz
director · 2026-09-01
Option exercise
117 shares
BARRY JAMES
EVP, President, LSG · 2026-09-01
Option exercise
251 shares
BARRY JAMES
EVP, President, LSG · 2026-09-01
Option exercise
174 shares
BARRY JAMES
EVP, President, LSG · 2026-09-01
Tax withholding
$59K
BARRY JAMES
EVP, President, LSG · 2026-09-01
Option exercise
425 shares
ENGELHARDT EVA ANETTE
EVP, President, CDG · 2026-07-25
Tax withholding
$28K
ENGELHARDT EVA ANETTE
EVP, President, CDG · 2026-07-25
Option exercise
246 shares
About Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing…
Medical - Devices
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works